Verizon Communications Inc
Ownership
Ownership Structure
Who owns Verizon Communications Inc (VZ)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.9% of the shares are freely tradable; institutional investors hold 70.3%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 9.58 | 398,216,158 | +8.2 | 06/30/2026 |
| Vanguard Capital Management, LLC | 6.23 | 258,996,106 | -0.5 | 06/30/2026 |
| State Street Corp | 5.05 | 209,676,274 | -2.4 | 06/30/2026 |
| Charles Schwab Investment Management Inc | 3.08 | 127,774,822 | +13.1 | 06/30/2026 |
| Geode Capital Management, LLC | 2.57 | 106,820,018 | +0.6 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 1.86 | 77,434,092 | +0.8 | 06/30/2026 |
| Morgan Stanley - Brokerage Accounts | 1.69 | 70,302,870 | -5.1 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 3.17 | 131,873,859 | +10.4 | 09/30/2026 |
| Vanguard 500 Index Investor | 2.63 | 109,110,418 | -1.6 | 09/30/2026 |
| Schwab US Dividend Equity ETF™ | 2.20 | 91,390,811 | +0.3 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Malady Kyle | EVP and Group CEO-VZ Business | 97,766 | 4,516,789 $ | Nov 3, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | Sell | 1,100 | 44.79 | 49,269 |
| Oct 27, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | Sell | 1,100 | 43.00 | 47,300 |
| Oct 20, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | Sell | 1,100 | 44.48 | 48,928 |
| Oct 13, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | Sell | 1,100 | 42.93 | 47,223 |
| Oct 6, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | Sell | 1,100 | 45.75 | 50,325 |
| Sep 29, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | Sell | 1,100 | 46.40 | 51,040 |
| Sep 22, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | Sell | 1,100 | 47.65 | 52,415 |
| Sep 15, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | Sell | 1,100 | 51.19 | 56,309 |
| Sep 8, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | Sell | 1,100 | 49.98 | 54,978 |
| Sep 1, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | Sell | 1,100 | 50.50 | 55,550 |
| Aug 25, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | Sell | 1,100 | 50.06 | 55,066 |
| Aug 18, 2026 | Malady Kyle | EVP and Group CEO-VZ Business | Sell | 1,100 | 48.68 | 53,548 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.